Meningococcal disease on the rise in the US
A rise in invasive serogroup Y meningococcal disease has prompted the Centers for Disease Control and Prevention (CDC) to issue a health advisory for health care providers.
Apr 12, 2024
0
1
A rise in invasive serogroup Y meningococcal disease has prompted the Centers for Disease Control and Prevention (CDC) to issue a health advisory for health care providers.
Apr 12, 2024
0
1
The Department of Clinical Medicine at the Miguel Hernández University of Elche (UMH) leads research on the immune system's role in advanced chronic liver disease. Through various experiments on mouse cirrhosis models and ...
Apr 10, 2024
0
0
Examining the immune cells in the environment around a tumor could help to predict how a person's cancer might progress and respond to treatment, according to new research led by UCL and the Francis Crick Institute.
Apr 10, 2024
0
0
The inflammation process plays a crucial role in allergic respiratory diseases, such as asthma and allergic rhinitis. Although the pulmonary epithelium, the carpet of cells that forms the inner surface of the lungs, is recognized ...
Apr 10, 2024
0
1
TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous cell cancer (HNSCC), according ...
Apr 9, 2024
0
14
Scientists have unraveled the mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) signaling pathway activated by micronuclei, as well as its significant ...
Apr 9, 2024
0
0
A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of ...
Apr 9, 2024
0
1
As a medical organization, Doctors Without Borders/Médecins Sans Frontières (MSF) is no stranger to measles, which has long been a serious and ongoing concern in many places where MSF operates.
Apr 9, 2024
0
1
The PD-1/CTLA-4 bispecific antibody cadonilimab plus chemotherapy improved progression-free survival and overall survival in patients with untreated, HER2-negative, locally advanced or metastatic gastric or gastroesophageal ...
Apr 8, 2024
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0